TRANSMEX

"The Balance between Transport and Mechanical Issues in 3D Regenerative Tissues, Using the Perfusion Bioreactor"

 Coordinatore CHARITE - UNIVERSITAETSMEDIZIN BERLIN 

 Organization address address: Chariteplatz 1
city: BERLIN
postcode: 10117

contact info
Titolo: Prof.
Nome: Georg
Cognome: Duda
Email: send email
Telefono: +49 30 4505 59079
Fax: +49 30 4505 59969

 Nazionalità Coordinatore Germany [DE]
 Totale costo 158˙694 €
 EC contributo 158˙694 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2007-2-1-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-04-01   -   2010-03-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    CHARITE - UNIVERSITAETSMEDIZIN BERLIN

 Organization address address: Chariteplatz 1
city: BERLIN
postcode: 10117

contact info
Titolo: Prof.
Nome: Georg
Cognome: Duda
Email: send email
Telefono: +49 30 4505 59079
Fax: +49 30 4505 59969

DE (BERLIN) coordinator 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

model    cellular    nutrients    balance    perfusion    tissue    constructs    harmful    bioreactors    stresses    cultured    engineered    scaffold    strategies    counterproductive    biological    pressure    culture    implications    transmex    engineering    offered    mechanical    transport    bioreactor    fluid    costly    cells    nutritional    death    deformation    rates    neo    nutrient    induced    experiments    minimise    flow    mechanically    advantages    encountered    tissues    cell   

 Obiettivo del progetto (Objective)

'Difficulties encountered in tissue engineering invited the use of perfusion bioreactors to deliver essential nutrients to cells within tissue-engineered constructs. Despite the increased nutrient transport achieved, solute perfusion caused harmful mechanical stresses to the cells. Interestingly, some bioreactors are employed to mechanically stimulate cells, improving their biological functions. However, stresses associated with perfusion bioreactors are counterproductive. Currently, to address this issue, perfusion rate is lowered to minimise mechanical implications to the cells. Consequently, nutrient delivery is sacrificed. Therefore, this project aims to balance the nutritional advantage offered by perfusion, and its associate cell-death. By doing so, essential nutrients may be perfused to all regions of tissue-engineered constructs, at flow rates whose mechanical implications are harmless, or even encouraging to cells. To alleviate the costly and iterative experiments necessary to achieve these aims, the use of computational modelling will be central to the project, and incidentally, forms the training objective of the proposal. However, key findings will be corroborated with laboratory experiments. Combining techniques associated with cell biology, material science, and mechanical engineering. The specific objectives of the proposed study are to: Model the fluid flow-induced deformation of cells within tissue-engineered constructs. Using fluorescent staining, corroborate relationship between fluid flow and cellular deformation. Design a system to mechanically deform cells without fluid flow. Investigate the influence of cellular deformation, with and without fluid flow to their viability and biological activities. Extrapolate the individual contributions of fluid flow and mechanical deformation. Determine theoretically, and experimentally, useful ranges of fluid flow and mechanical deformation, conducive to developing functional neo-tissues in vitro.'

Introduzione (Teaser)

The problems encountered in delivering essential nutrients to engineered tissues resulted in the introduction of perfusion bioreactors to work with cells cultured in 3D scaffolds. However, pressure generated by fluid flow during molecule transportation often harms the cells, sometimes even rendering them unusable.

Descrizione progetto (Article)

Although perfusion bioreactors have been successfully used to increase nutrient transport, it can often be a counterproductive process if it exerts harmful mechanical stresses on cultured cells. Lowering perfusion rates to minimise such negative outcomes can result in inadequate nutrient delivery once more.

'The balance between transport and mechanical issues in 3d regenerative tissues, using the perfusion bioreactor' (Transmex) is a project that aimed to find the balance between nutritional advantages offered by perfusion and associated cell-death. Specifically, the EU-funded project set out to model the fluid flow-induced deformation of cells in tissue-engineered constructs.

In activities directed at uncovering the advantages and limitations of media perfusion for neo-tissue development, researchers demonstrated an operational range of beneficial perfusion as well as the parameters defining this range. Results clearly showed the need to identify a perfusion system's operational capacity and the cell-scaffold model. In this way, a culture strategy can be maximised for efficient nutrient supply without applying detrimental pressure to either the cells or their seeding scaffold.

Since bioreactor pressure build-up during direct perfusion cannot be avoided, perfusion times logically dictate if there will be damage to the tissue and if the culture will be compromised. By acknowledging that pressures and timing differ from system to system, Transmex project partners proposed that tissue-engineering strategies should be adapted in accordance with the system in use. This will afford the means to monitor differential pressure inside a perfusion culture system and, using a range of flow rates, profile the time frame within which pressure becomes harmful. Online monitoring during perfusion culture means that high and low flow rates can be used interchangeably to optimise nutrient delivery to cells within safe pressure limits.

Transmex project results can be used by the scientists and clinicians to develop optimal strategies for tissue regeneration. Achievements in this area will significantly contribute to international health-care system efforts to abate the burden of costly diseases.

Altri progetti dello stesso programma (FP7-PEOPLE)

EULAMDIMA (2012)

Joint European and Latin American Research Network on Diabetic Microangiopathy

Read More  

ALPES (2013)

Aircraft Loads Prediction for Enhanced Simulation

Read More  

CLIMBIOHOTSPOTS (2008)

Climate Change and Areas with High Species Diversity at Global Scale

Read More